ASH 2023 | The value of WGS and whole transcriptome sequencing in the diagnosis of hematological malignancies
In this video, Torsten Haferlach, MD, PhD, MLL Munich Leukemia Laboratory, Munich, Germany, discusses the value of whole genome sequencing (WGS) and whole transcriptome sequencing in diagnosing hematological malignancies. Prof. Haferlach believes that in the near future, once barriers to their implementation have been addressed, these techniques will be utilized in routine clinical practice for the diagnosis of leukemias, lymphomas, and other malignancies. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
MLL Munich Leukemia Laboratory: Current Employment; Other: Equity Ownership.
